Community Bank System, Inc. (CBU) Analysts See $0.59 EPS, Theravance Biopharma Has 1.73 Sentiment

July 13, 2017 - By Kurt Siggers

Analysts expect Community Bank System, Inc. (NYSE:CBU) to report $0.59 EPS on July, 19.They anticipate $0.01 EPS change or 1.72% from last quarter’s $0.58 EPS. CBU’s profit would be $26.95 million giving it 23.47 P/E if the $0.59 EPS is correct. After having $0.64 EPS previously, Community Bank System, Inc.’s analysts see -7.81% EPS growth. The stock increased 0.31% or $0.17 during the last trading session, reaching $55.38. About shares traded. Community Bank System, Inc. (NYSE:CBU) has risen 36.75% since July 13, 2016 and is uptrending. It has outperformed by 20.05% the S&P500.

Theravance Biopharma, Inc. is a biopharmaceutical company. The company has market cap of $2.14 billion. The Firm is engaged in creating medicines for patients suffering from serious illness. It currently has negative earnings. The Firm operates in the segment of discovery , development and commercialization of human therapeutics.

Since January 26, 2017, it had 0 insider purchases, and 5 sales for $1.84 million activity. Kingsley Scott Allen sold $335,654 worth of stock or 5,435 shares. Whipple John F. sold 3,850 shares worth $230,881. Parente John had sold 5,000 shares worth $307,800 on Thursday, January 26. Mucenski Edward S. sold $173,884 worth of stock or 3,000 shares. GABRIEL JAMES A also sold $795,326 worth of Community Bank System, Inc. (NYSE:CBU) on Thursday, January 26.

Investors sentiment decreased to 1.27 in Q4 2016. Its down 0.33, from 1.6 in 2016Q3. It dropped, as 7 investors sold Community Bank System, Inc. shares while 53 reduced holdings. 25 funds opened positions while 51 raised stakes. 30.18 million shares or 4.02% more from 29.02 million shares in 2016Q3 were reported. Tiaa Cref Ltd Liability Co reported 0.01% in Community Bank System, Inc. (NYSE:CBU). Aqr Capital Management Lc stated it has 0% of its portfolio in Community Bank System, Inc. (NYSE:CBU). Thrivent Fincl For Lutherans holds 0.01% or 24,050 shares. Rhumbline Advisers owns 80,770 shares. Raymond James And accumulated 17,668 shares. Tower Research Capital Limited Liability Co (Trc) stated it has 0% of its portfolio in Community Bank System, Inc. (NYSE:CBU). State Of Tennessee Treasury Department accumulated 35,154 shares. 121,800 were reported by Renaissance Technologies Lc. State Board Of Administration Of Florida Retirement System reported 0.01% of its portfolio in Community Bank System, Inc. (NYSE:CBU). Nottingham Advsrs holds 149,442 shares. Moreover, Blackrock has 0% invested in Community Bank System, Inc. (NYSE:CBU) for 10,944 shares. 29,458 are owned by Metropolitan Life Insurance Comm New York. 141,364 were reported by Ny State Teachers Retirement Systems. Fifth Third Savings Bank has 3,954 shares for 0% of their portfolio. California Pub Employees Retirement Sys stated it has 0.01% of its portfolio in Community Bank System, Inc. (NYSE:CBU).

Among 7 analysts covering Community Bank Systems (NYSE:CBU), 0 have Buy rating, 1 Sell and 6 Hold. Therefore 0 are positive. Community Bank Systems had 11 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Piper Jaffray with “Neutral” on Thursday, January 7. RBC Capital Markets maintained the stock with “Sector Perform” rating in Tuesday, December 8 report. As per Friday, July 22, the company rating was downgraded by Sandler O’Neill. The firm has “Buy” rating given on Friday, January 22 by Sandler O’Neill. The firm has “Market Perform” rating given on Tuesday, October 25 by Hovde Group. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, January 22. The stock of Community Bank System, Inc. (NYSE:CBU) earned “Hold” rating by Zacks on Tuesday, September 22. Sandler O’Neill downgraded the shares of CBU in report on Thursday, January 12 to “Sell” rating.

Community Bank System, Inc. is a bank holding company. The company has market cap of $2.53 billion. The Firm owns two subsidiaries: Community Bank, N.A. and Benefit Plans Administrative Services, Inc. (BPAS). It has a 23.68 P/E ratio. It operates in three divisions: banking, employee benefit services, and All Other.

Ratings analysis reveals 50% of Theravance Biopharma’s analysts are positive. Out of 2 Wall Street analysts rating Theravance Biopharma, 1 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. The lowest target is $24.0 while the high is $40.0. The stock’s average target of $32 is -20.65% below today’s ($40.33) share price. TBPH was included in 2 notes of analysts from October 12, 2016. The rating was initiated by Needham with “Buy” on Wednesday, December 21. As per Wednesday, October 12, the company rating was downgraded by Robert W. Baird.

Since January 1, 0001, it had 0 buys, and 2 selling transactions for $1.30 million activity.